<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02539290</url>
  </required_header>
  <id_info>
    <org_study_id>2015-1146</org_study_id>
    <nct_id>NCT02539290</nct_id>
  </id_info>
  <brief_title>Preovulatory Uterine Flushing With Saline as a Treatment for Unexplained Infertility</brief_title>
  <official_title>Preovulatory Uterine Flushing With Saline as a Treatment for Unexplained Infertility: A Randomised Controlled Trial Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Quebec-Universite Laval</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Quebec-Universite Laval</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether preovulatory uterine flushing with
      physiological saline is effective in the treatment of unexplained infertility.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In vitro fertilisation is the only current reasonable treatment for unexplained infertility.
      Uterine flushing, associated with a five-fold increase in pregnancy when performed
      preovulatory, has been proposed as a new alternative. This treatment could flush out debris
      or alter inflammatory factors preventing fertilisation and implantation. The objective of
      this study is to assess the efficacy of pre-ovulatory uterine flushing with physiological
      saline for the treatment of unexplained infertility. This study is a randomised controlled
      trial based on consecutive women aged between 18 and 37 years consulting for unexplained
      infertility for at least one year. The day of their luteinizing hormone surge, 192
      participants will be randomised in two equal groups to either receive 20 millilitres of
      physiological saline by an intra-uterine catheter or 10 millilitres of saline intravaginally.
      Investigators will assess relative risk of live birth (primary outcome), as well as pregnancy
      over one cycle of treatment. Side effects, complications, and acceptability of the
      intervention will be reported.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of participants with a live birth resulting from one cycle of treatment</measure>
    <time_frame>10 months after randomisation</time_frame>
    <description>Proportion of participants with a live birth resulting from one cycle of treatment based on questionnaire and medical data.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of participants with a pregnancy resulting from one cycle of treatment</measure>
    <time_frame>One month after randomisation</time_frame>
    <description>Proportion of participants with a positive urinary or serum pregnancy test, gestational sac on ultrasound or histological evidence of trophoblastic tissue resulting from one cycle of treatment based on questionnaire and medical data.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects</measure>
    <time_frame>One month after randomisation</time_frame>
    <description>Number of participants with treatment-related pain, vagal symptoms, nausea, vomiting, temperature, pelvic infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of participants who find the intervention acceptable</measure>
    <time_frame>One month after randomisation</time_frame>
    <description>Proportion of participants that would be willing to receive the intervention for a second time and find the intervention acceptable.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">192</enrollment>
  <condition>Unexplained Infertility</condition>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Uterine flushing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Detection of ovulation, injection of 20 millilitres of physiological saline by an intra-uterine catheter the day of the luteinizing hormone surge, and sexual intercourse within 12 hours after intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vaginal flushing</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Detection of ovulation, injection of 10 millilitres of physiological saline intravaginally the day of the luteinizing hormone surge, and sexual intercourse within 12 hours after intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Detection of ovulation</intervention_name>
    <description>Detecting the luteinizing hormone surge using test sticks in a urine sample</description>
    <arm_group_label>Uterine flushing</arm_group_label>
    <arm_group_label>Vaginal flushing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Uterine flushing</intervention_name>
    <description>Injection of 20 millilitres of physiological saline by an intra-uterine catheter the day of the luteinizing hormone surge</description>
    <arm_group_label>Uterine flushing</arm_group_label>
    <other_name>Tubal flushing</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vaginal flushing</intervention_name>
    <description>Injection of 10 millilitres of physiological saline intravaginally the day of the luteinizing hormone surge</description>
    <arm_group_label>Vaginal flushing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sexual intercourse</intervention_name>
    <description>Sexual intercourse within 12 hours after intervention</description>
    <arm_group_label>Uterine flushing</arm_group_label>
    <arm_group_label>Vaginal flushing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary or secondary infertility ≥12 months.

          -  Diagnosis of unexplained infertility ≤36 months:

               -  Anti-Mullerian hormone ≥0.4 ng/mL and/or follicle-stimulating hormone ≤13 IU/L in
                  early follicular phase;

               -  regular cycle of 25-35 days,

               -  positive ovulation tests, and/or

               -  luteal phase serum progesterone ≥25mmol/L in a natural cycle;

               -  normal semen analysis;

               -  normal uterine cavity;

               -  patent tubes.

          -  Negative genitourinary test for gonorrhoea and chlamydia ≤12 months.

        Exclusion Criteria:

          -  Body mass index ≥35 kg/m2.

          -  Ongoing pregnancy.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>37 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sylvie Dodin, MD-MSc</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Universitaire de Quebec</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Maheux, MD-MSc</last_name>
    <phone>1-418-525-4444</phone>
    <email>sarah.maheux.lacroix@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sylvie Dodin, MD-MSc</last_name>
    <phone>1-418-656-2131</phone>
    <email>sylvie.dodin@fmed.ulaval.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Quebec</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4G2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Maheux-Lacroix, MD-MSc</last_name>
      <phone>1-418-525-4444</phone>
      <email>sarah.maheux.lacroix@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Sylvie Dodin, MD-MSc</last_name>
      <phone>1-418-656-2131</phone>
      <email>sylvie.dodin@fmed.ulaval.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2015</study_first_submitted>
  <study_first_submitted_qc>August 31, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2015</study_first_posted>
  <last_update_submitted>March 2, 2017</last_update_submitted>
  <last_update_submitted_qc>March 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Unexplained infertility</keyword>
  <keyword>Infertility</keyword>
  <keyword>Tubal flushing</keyword>
  <keyword>Uterine flushing</keyword>
  <keyword>Live birth</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Randomized controlled trial</keyword>
  <keyword>Saline</keyword>
  <keyword>Physiological saline</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Flushing</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

